Nocebos in rheumatology: emerging concepts and their implications for clinical practice
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nocebos in rheumatology: emerging concepts and their implications for clinical practice
Authors
Keywords
-
Journal
Nature Reviews Rheumatology
Volume 14, Issue 12, Pages 727-740
Publisher
Springer Nature America, Inc
Online
2018-10-26
DOI
10.1038/s41584-018-0110-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical relevance of contextual factors as triggers of placebo and nocebo effects in musculoskeletal pain
- (2018) Giacomo Rossettini et al. BMC MUSCULOSKELETAL DISORDERS
- Comparison of injection-site reactions between the etanercept biosimilar SB4 and the reference etanercept in patients with rheumatoid arthritis from a phase III study
- (2018) G. Girolomoni et al. BRITISH JOURNAL OF DERMATOLOGY
- The nocebo effect challenges the non-medical infliximab switch in practice
- (2018) N. W. Boone et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Does Googling lead to statin intolerance?
- (2018) Sarah Khan et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Autonomic Arousal as a Mechanism of the Persistence of Nocebo Hyperalgesia
- (2018) Ben Colagiuri et al. JOURNAL OF PAIN
- Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care
- (2018) B Glintborg et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Acceptance Rate And Sociological Factors Involved In The Switch From Originator To Biosimilar Etanercept (SB4)
- (2018) Marc Scherlinger et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, France
- (2018) Jérôme Avouac et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- An Extension Study of PF-05280586, a Potential Rituximab Biosimilar, versus Rituximab in Subjects with Active Rheumatoid Arthritis
- (2018) Stanley B Cohen et al. ARTHRITIS CARE & RESEARCH
- Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study
- (2018) Rishi J Desai et al. BMJ-British Medical Journal
- Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study
- (2018) Rishi J Desai et al. BMJ-British Medical Journal
- Open-Label Non-Mandatory Transitioning From Originator Etanercept to Biosimilar SB4: 6-Month Results From a Controlled Cohort Study
- (2018) Lieke Tweehuysen et al. Arthritis & Rheumatology
- Switching From Reference Adalimumab to SB5 (Adalimumab Biosimilar) in Patients With Rheumatoid Arthritis
- (2018) Michael E. Weinblatt et al. Arthritis & Rheumatology
- Switching from originator infliximab to biosimilar CT-P13 in real-life: The weight of patient acceptance
- (2017) Marc Scherlinger et al. JOINT BONE SPINE
- Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase
- (2017) Ajay Gupta et al. LANCET
- Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial
- (2017) Kristin K Jørgensen et al. LANCET
- Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
- (2017) Michael E. Wechsler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nocebo effects can make you feel pain
- (2017) Luana Colloca SCIENCE
- Interactions between brain and spinal cord mediate value effects in nocebo hyperalgesia
- (2017) A. Tinnermann et al. SCIENCE
- Influence of Morphine and Naloxone on Pain Modulation in Rheumatoid Arthritis, Chronic Fatigue Syndrome/Fibromyalgia, and Controls: A Double-Blind, Randomized, Placebo-Controlled, Cross-Over Study
- (2017) Linda Hermans et al. Pain Practice
- Phase III Randomized Study of SB5, an Adalimumab Biosimilar, Versus Reference Adalimumab in Patients With Moderate-to-Severe Rheumatoid Arthritis
- (2017) Michael E. Weinblatt et al. Arthritis & Rheumatology
- Subjective Complaints as the Main Reason for Biosimilar Discontinuation After Open-Label Transition From Reference Infliximab to Biosimilar Infliximab
- (2017) Lieke Tweehuysen et al. Arthritis & Rheumatology
- A systematic review of sex differences in the placebo and the nocebo effect
- (2017) Sara Vambheim et al. Journal of Pain Research
- Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians
- (2016) Hillel Cohen et al. ADVANCES IN THERAPY
- Examination of overall treatment effect and the proportion attributable to contextual effect in osteoarthritis: meta-analysis of randomised controlled trials
- (2016) Kun Zou et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study
- (2016) Won Park et al. ANNALS OF THE RHEUMATIC DISEASES
- A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis
- (2016) Dae Hyun Yoo et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study
- (2016) Dae Hyun Yoo et al. ANNALS OF THE RHEUMATIC DISEASES
- A phase I pharmacokinetics trial comparing PF-05280586 (a potential biosimilar) and rituximab in patients with active rheumatoid arthritis
- (2016) Stanley Cohen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Nocebo in headache
- (2016) Dimos D. Mitsikostas CURRENT OPINION IN NEUROLOGY
- Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases
- (2016) Stefano Gentileschi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis: a 6-month real-life observational study
- (2016) Maurizio Benucci et al. IMMUNOLOGIC RESEARCH
- Lessons Learned From Nocebo Effects in Clinical Trials for Pain Conditions and Neurodegenerative Disorders
- (2016) Martina Amanzio et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Patient Perspectives on Biosimilars: A Survey by the European Federation of Crohn’s and Ulcerative Colitis Associations: Table 1.
- (2016) Laurent Peyrin-Biroulet et al. Journal of Crohns & Colitis
- Safety and efficacy of CT-P13 in Japanese patients with rheumatoid arthritis in an extension phase or after switching from infliximab
- (2016) Yoshiya Tanaka et al. Modern Rheumatology
- The power and value of placebo and nocebo in painful osteoarthritis
- (2016) P. Dieppe et al. OSTEOARTHRITIS AND CARTILAGE
- Pain facilitation and pain inhibition during conditioned pain modulation in fibromyalgia and in healthy controls
- (2016) Stéphane Potvin et al. PAIN
- Changes in perception of treatment efficacy are associated to the magnitude of the nocebo effect and to personality traits
- (2016) Nicole Corsi et al. Scientific Reports
- Effectiveness and Implications of Alternative Placebo Treatments
- (2015) Raveendhara R. Bannuru et al. ANNALS OF INTERNAL MEDICINE
- A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy
- (2015) Jung-Yoon Choe et al. ANNALS OF THE RHEUMATIC DISEASES
- A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy
- (2015) Paul Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Pharmacokinetic Bioequivalence, Safety, and Immunogenicity of DMB-3111, a Trastuzumab Biosimilar, and Trastuzumab in Healthy Japanese Adult Males: Results of a Randomized Trial
- (2015) Jun Morita et al. BIODRUGS
- Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data
- (2015) Elena Nikiphorou et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Accentuate the positive: Counteracting psychogenic responses to media health messages in the age of the Internet
- (2015) Fiona Crichton et al. JOURNAL OF PSYCHOSOMATIC RESEARCH
- The indirect pathway of the nucleus accumbens shell amplifies neuropathic pain
- (2015) Wenjie Ren et al. NATURE NEUROSCIENCE
- Biosimilars in rheumatology: current perspectives and lessons learnt
- (2015) Thomas Dörner et al. Nature Reviews Rheumatology
- Neural underpinnings of nocebo hyperalgesia in visceral pain: A fMRI study in healthy volunteers
- (2015) Julia Schmid et al. NEUROIMAGE
- Distinct neural representations of placebo and nocebo effects
- (2015) Sonya Freeman et al. NEUROIMAGE
- Nociception, Pain, Negative Moods, and Behavior Selection
- (2015) Marwan N. Baliki et al. NEURON
- Touch inhibits subcortical and cortical nociceptive responses
- (2015) Flavia Mancini et al. PAIN
- Measuring nonspecific factors in treatment: item banks that assess the healthcare experience and attitudes from the patient’s perspective
- (2015) Carol M. Greco et al. QUALITY OF LIFE RESEARCH
- Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review
- (2015) Sarah Colgan et al. BMJ Open
- A Neural Mechanism for Nonconscious Activation of Conditioned Placebo and Nocebo Responses
- (2014) Karin B. Jensen et al. CEREBRAL CORTEX
- Pain anticipation: An activation likelihood estimation meta-analysis of brain imaging studies
- (2014) Sara Palermo et al. HUMAN BRAIN MAPPING
- Medicine's inconvenient truth: the placebo and nocebo effect
- (2014) M. H. Arnold et al. INTERNAL MEDICINE JOURNAL
- Avoiding Nocebo Effects to Optimize Treatment Outcome
- (2014) Ulrike Bingel JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Q-No: a questionnaire to predict nocebo in outpatients seeking neurological consultation
- (2014) Dimos D. Mitsikostas et al. NEUROLOGICAL SCIENCES
- Sustained Remission with Etanercept Tapering in Early Rheumatoid Arthritis
- (2014) Paul Emery et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nocebo and placebo modulation of hypobaric hypoxia headache involves the cyclooxygenase-prostaglandins pathway
- (2014) Fabrizio Benedetti et al. PAIN
- Use of ClinicalTrials.gov to Estimate Condition-Specific Nocebo Effects and Other Factors Affecting Outcomes of Analgesic Trials
- (2013) M. Soledad Cepeda et al. JOURNAL OF PAIN
- Using Sherlock and ClinicalTrials.gov Data to Understand Nocebo Effects and Adverse Event Dropout Rates in the Placebo Arm
- (2013) M. Soledad Cepeda et al. JOURNAL OF PAIN
- Nocebo hyperalgesia induced by social observational learning
- (2013) Elisabeth Vögtle et al. PAIN
- Saying Things the “Right” Way: Avoiding “Nocebo” Effects and Providing Full Informed Consent
- (2012) Jeremy Howick AMERICAN JOURNAL OF BIOETHICS
- To Tell the Truth, the Whole Truth, May Do Patients Harm: The Problem of the Nocebo Effect for Informed Consent
- (2012) Rebecca Erwin Wells et al. AMERICAN JOURNAL OF BIOETHICS
- Individual magnetic resonance imaging and radiographic features of knee osteoarthritis in subjects with unilateral knee pain: The Health, Aging, and Body Composition Study
- (2012) M. K. Javaid et al. ARTHRITIS AND RHEUMATISM
- Development of the Stanford Expectations of Treatment Scale (SETS): A tool for measuring patient outcome expectancy in clinical trials
- (2012) Jarred Younger et al. Clinical Trials
- Nocebo Effects, Patient-Clinician Communication, and Therapeutic Outcomes
- (2012) Luana Colloca et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Effect of an Apparent Change to a Branded or Generic Medication on Drug Effectiveness and Side Effects
- (2012) Kate Faasse et al. PSYCHOSOMATIC MEDICINE
- Impact of television coverage on the number and type of symptoms reported during a health scare: a retrospective pre–post observational study
- (2012) Kate Faasse et al. BMJ Open
- Mechanisms of Chronic Pain in Osteoarthritis
- (2012) Hans-Georg Schaible Current Rheumatology Reports
- Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE
- (2011) Paul P Tak et al. ANNALS OF THE RHEUMATIC DISEASES
- Unawareness of deficits in Alzheimer’s disease: role of the cingulate cortex
- (2011) Martina Amanzio et al. BRAIN
- Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches
- (2011) Dimos D Mitsikostas et al. CEPHALALGIA
- Mechanisms Involved in Placebo and Nocebo Responses and Implications for Drug Trials
- (2011) W Rief et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Nocebo in Headaches: Implications for Clinical Practice and Trial Design
- (2011) Dimos D. Mitsikostas Current Neurology and Neuroscience Reports
- Nocebo in fibromyalgia: meta-analysis of placebo-controlled clinical trials and implications for practice
- (2011) D. D. Mitsikostas et al. EUROPEAN JOURNAL OF NEUROLOGY
- Induction of nocebo and placebo effects on itch and pain by verbal suggestions
- (2011) Antoinette I.M. van Laarhoven et al. PAIN
- The Nocebo Effect and Its Relevance for Clinical Practice
- (2011) Luana Colloca et al. PSYCHOSOMATIC MEDICINE
- Prevalence of anxiety and depression in osteoarthritis: use of the Hospital Anxiety and Depression Scale as a screening tool
- (2010) John Axford et al. CLINICAL RHEUMATOLOGY
- Nonspecific side effects of oral contraceptives: nocebo or noise?
- (2010) David A. Grimes et al. CONTRACEPTION
- Insular Cortex Activity Is Associated with Effects of Negative Expectation on Nociceptive Long-Term Habituation
- (2010) R. Rodriguez-Raecke et al. JOURNAL OF NEUROSCIENCE
- Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans
- (2010) Irene Tracey NATURE MEDICINE
- Predicting Value of Pain and Analgesia: Nucleus Accumbens Response to Noxious Stimuli Changes in the Presence of Chronic Pain
- (2010) Marwan N. Baliki et al. NEURON
- Disruption of opioid-induced placebo responses by activation of cholecystokinin type-2 receptors
- (2010) Fabrizio Benedetti et al. PSYCHOPHARMACOLOGY
- Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines
- (2010) Yvonne Nestoriuc et al. ARTHRITIS CARE & RESEARCH
- Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patients
- (2009) Stephen E. Gwilym et al. ARTHRITIS AND RHEUMATISM
- Gender and the nocebo response following conditioning and expectancy
- (2009) Sibylle Klosterhalfen et al. JOURNAL OF PSYCHOSOMATIC RESEARCH
- A systematic review of adverse events in placebo groups of anti-migraine clinical trials
- (2009) Martina Amanzio et al. PAIN
- Placebo analgesia induced by social observational learning
- (2009) Luana Colloca et al. PAIN
- Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis
- (2009) Johann D. Ringe et al. RHEUMATOLOGY INTERNATIONAL
- The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials
- (2008) W Zhang et al. ANNALS OF THE RHEUMATIC DISEASES
- Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate
- (2008) G Wells et al. ANNALS OF THE RHEUMATIC DISEASES
- A Functional Magnetic Resonance Imaging Study on the Neural Mechanisms of Hyperalgesic Nocebo Effect
- (2008) J. Kong et al. JOURNAL OF NEUROSCIENCE
- The role of learning in nocebo and placebo effects
- (2008) L. Colloca et al. PAIN
- Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
- (2008) Ted J Kaptchuk et al. BMJ-British Medical Journal
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started